» Articles » PMID: 4359489

Phosphorylation of 5-bromodeoxycytidine in Cells Infected with Herpes Simplex Virus

Overview
Specialty Science
Date 1973 Dec 1
PMID 4359489
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

5-Bromodeoxycytidine is phosphorylated to 5-bromodeoxycytidine 5'-monophosphate in extracts of cells infected with herpes simplex virus but not in extracts of uninfected cells. The conversion of 5-bromodeoxycytidine to nucleotides and its utilization for DNA synthesis in uninfected cells occurs by deamination of 5-bromodeoxycytidine to 5-bromodeoxyuridine followed by phosphorylation of 5-bromodeoxyuridine to 5-bromodeoxyuridine 5'-monophosphate. In contrast, in cells infected with herpes simplex virus, 5-bromodeoxycytidine is phosphorylated directly to 5-bromodeoxycytidine 5'-monophosphate, which can then be deaminated to 5-bromodeoxyuridine 5'-monophosphate and incorporated into DNA. These results indicate a difference in the substrate specificity of nucleoside kinases induced by herpes simplex virus and the enzymes present in uninfected cells. It is suggested that this difference in substrate specificity between virus-induced and host-cell enzymes may allow selective chemotherapy of herpes simplex infections with 5-bromo- or 5-iododeoxycytidine.

Citing Articles

Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus.

Connor J, Sweetman L, Carey S, Stuckey M, Buchanan R Antimicrob Agents Chemother. 1974; 6(5):630-6.

PMID: 15825318 PMC: 444705. DOI: 10.1128/AAC.6.5.630.


Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.

Tenser R, Gaydos A, Hay K J Virol. 1996; 70(2):1271-6.

PMID: 8551594 PMC: 189942. DOI: 10.1128/JVI.70.2.1271-1276.1996.


Incorporation of 5-substituted analogs of deoxycytidine into DNA of herpes simplex virus-infected or - transformed cells without deamination to the thymidine analog.

Fox L, Dobersen M, Greer S Antimicrob Agents Chemother. 1983; 23(3):465-76.

PMID: 6303214 PMC: 184670. DOI: 10.1128/AAC.23.3.465.


Capacity of deoxycytidine to selectively antagonize cytotoxicity of 5-halogenated analogs of deoxycytidine without loss of antiherpetic activity.

Fox L, Mekras J, Bagwell C, GREER S Antimicrob Agents Chemother. 1982; 22(3):431-41.

PMID: 6291452 PMC: 183762. DOI: 10.1128/AAC.22.3.431.


Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.

Panicali D, Paoletti E Proc Natl Acad Sci U S A. 1982; 79(16):4927-31.

PMID: 6289324 PMC: 346798. DOI: 10.1073/pnas.79.16.4927.


References
1.
BRESNICK E, Thompson U . Properties of deoxythymidine kinase partially purified from animal tumors. J Biol Chem. 1965; 240(10):3967-74. View

2.
Kaufmann H . In vivo studies with antiviral agents. Ann N Y Acad Sci. 1965; 130(1):168-80. DOI: 10.1111/j.1749-6632.1965.tb12550.x. View

3.
LEOPOLD I . Clinical experience with nucleosides in herpes simplex eye infections in man and animals. Ann N Y Acad Sci. 1965; 130(1):181-91. DOI: 10.1111/j.1749-6632.1965.tb12551.x. View

4.
RENIS H, Buthala D . Development of resistance to antiviral drugs. Ann N Y Acad Sci. 1965; 130(1):343-54. DOI: 10.1111/j.1749-6632.1965.tb12568.x. View

5.
CAMIENER G, Smith C . Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity. Biochem Pharmacol. 1965; 14(10):1405-16. DOI: 10.1016/0006-2952(65)90175-9. View